Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hinge Health, Inc. Class A ( (HNGE) ) has shared an announcement.
Hinge Health reported record fourth-quarter and full-year 2025 results on February 10, 2026, highlighted by 46% year-on-year revenue growth in Q4 to $170.7 million, expanded gross margins and sharply higher operating income and cash generation. For 2025, revenue rose 51% to $587.9 million, non-GAAP operations swung to a $119.5 million profit, free cash flow nearly quadrupled and key operating metrics, including clients, contracted lives and members, all posted strong double-digit growth.
The company’s Rule of 40 metric improved to 81 from 45, underscoring a rare combination of rapid growth and rising profitability in digital health, while cash and investments reached $478.8 million at year-end. Management also highlighted a $250 million share repurchase program authorized in November 2025, of which $65 million was deployed in the fourth quarter, signaling confidence in the business and offering potential upside for shareholders as Hinge Health consolidates its leadership in the musculoskeletal segment.
The most recent analyst rating on (HNGE) stock is a Buy with a $60.00 price target. To see the full list of analyst forecasts on Hinge Health, Inc. Class A stock, see the HNGE Stock Forecast page.
Spark’s Take on HNGE Stock
According to Spark, TipRanks’ AI Analyst, HNGE is a Neutral.
The score is driven by strong financial momentum and improving cash flow, reinforced by a positive earnings call with raised guidance and better operating metrics. These positives are tempered by very weak technicals (deeply oversold and below key moving averages) and limited/less-informative valuation signals due to negative earnings and no dividend yield provided.
To see Spark’s full report on HNGE stock, click here.
More about Hinge Health, Inc. Class A
Hinge Health, Inc., based in San Francisco, operates in digital musculoskeletal care, using an AI-powered care model, wearable devices and expert clinicians to deliver personalized, evidence-based treatment for pain. The company focuses on automating and scaling healthcare delivery to improve member outcomes and reduce costs for employer and health plan clients.
Average Trading Volume: 1,373,577
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.45B
Learn more about HNGE stock on TipRanks’ Stock Analysis page.